Cargando…

An Examination of Risk Factors for Tobacco and Cannabis Smoke Exposure in Adolescents Using an Epigenetic Biomarker

Objective: Evolving patterns of nicotine and cannabis use by adolescents require new tools to understand the changing epidemiology of these substances. Here we describe the use of a novel epigenetic biomarker sensitive to both tobacco and cannabis smoke in a longitudinal sample of high-risk adolesce...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Allan, Gerrard, Meg, Gibbons, Frederick X., Beach, Steven R. H., Philibert, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421639/
https://www.ncbi.nlm.nih.gov/pubmed/34504443
http://dx.doi.org/10.3389/fpsyt.2021.688384
_version_ 1783749126131810304
author Andersen, Allan
Gerrard, Meg
Gibbons, Frederick X.
Beach, Steven R. H.
Philibert, Robert
author_facet Andersen, Allan
Gerrard, Meg
Gibbons, Frederick X.
Beach, Steven R. H.
Philibert, Robert
author_sort Andersen, Allan
collection PubMed
description Objective: Evolving patterns of nicotine and cannabis use by adolescents require new tools to understand the changing epidemiology of these substances. Here we describe the use of a novel epigenetic biomarker sensitive to both tobacco and cannabis smoke in a longitudinal sample of high-risk adolescents. We examine risk factors for positivity for this epigenetic biomarker in comparison to positivity for conventional serum biomarkers of nicotine and cannabis use. Method: Eastern Iowa 10th graders who had a friend or family member who smoked were eligible to participate in a longitudinal study over 10–12th grades. Subjects provided self-report data on nicotine, tobacco, and cannabis use patterns as well as blood samples that were used for serum cotinine and THC assays. DNA was prepared for analysis of methylation at the CpG cg05575921, a sensitive indicator of smoke exposure. Relationships between positivity for each these biomarkers and a variety of risk factors, including demographics, family and peer relationships, psychopathology, willingness to smoke, and perceptions of typical cigarette and cannabis users, were examined at the 10th (n = 442), 11th (n = 376), and 12th (n = 366) grade timepoints. Results: A increasing proportion of subjects were positive for cotinine (5–16%), THC (3–10%), and cg05575921 methylation (5–7%) across timepoints, with some overlap. Self-reported combusted tobacco and cannabis use was strongly correlated with all biomarkers, whereas cg05575921 methylation was not correlated with reported e-cigarette use. Dual users, defined as those positive for nicotine and THC in the 12th grade showed the greatest cumulative smoke exposure, indicated by cg05575921 methylation. Subjects reported more positive attitudes toward cannabis users than cigarette smokers, and willingness to smoke and positive perceptions of tobacco and cannabis smokers were significant risk factors for biomarker positivity across timepoints. Conclusion: We conclude that measurement of cg05575921 methylation in adolescents is a useful tool in detecting tobacco smoking in adolescents, and may be a novel tool for the detection of cannabis smoking and cannabis and tobacco co-use, though non-combusted forms of nicotine use do not appear to be detectable by this method.
format Online
Article
Text
id pubmed-8421639
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84216392021-09-08 An Examination of Risk Factors for Tobacco and Cannabis Smoke Exposure in Adolescents Using an Epigenetic Biomarker Andersen, Allan Gerrard, Meg Gibbons, Frederick X. Beach, Steven R. H. Philibert, Robert Front Psychiatry Psychiatry Objective: Evolving patterns of nicotine and cannabis use by adolescents require new tools to understand the changing epidemiology of these substances. Here we describe the use of a novel epigenetic biomarker sensitive to both tobacco and cannabis smoke in a longitudinal sample of high-risk adolescents. We examine risk factors for positivity for this epigenetic biomarker in comparison to positivity for conventional serum biomarkers of nicotine and cannabis use. Method: Eastern Iowa 10th graders who had a friend or family member who smoked were eligible to participate in a longitudinal study over 10–12th grades. Subjects provided self-report data on nicotine, tobacco, and cannabis use patterns as well as blood samples that were used for serum cotinine and THC assays. DNA was prepared for analysis of methylation at the CpG cg05575921, a sensitive indicator of smoke exposure. Relationships between positivity for each these biomarkers and a variety of risk factors, including demographics, family and peer relationships, psychopathology, willingness to smoke, and perceptions of typical cigarette and cannabis users, were examined at the 10th (n = 442), 11th (n = 376), and 12th (n = 366) grade timepoints. Results: A increasing proportion of subjects were positive for cotinine (5–16%), THC (3–10%), and cg05575921 methylation (5–7%) across timepoints, with some overlap. Self-reported combusted tobacco and cannabis use was strongly correlated with all biomarkers, whereas cg05575921 methylation was not correlated with reported e-cigarette use. Dual users, defined as those positive for nicotine and THC in the 12th grade showed the greatest cumulative smoke exposure, indicated by cg05575921 methylation. Subjects reported more positive attitudes toward cannabis users than cigarette smokers, and willingness to smoke and positive perceptions of tobacco and cannabis smokers were significant risk factors for biomarker positivity across timepoints. Conclusion: We conclude that measurement of cg05575921 methylation in adolescents is a useful tool in detecting tobacco smoking in adolescents, and may be a novel tool for the detection of cannabis smoking and cannabis and tobacco co-use, though non-combusted forms of nicotine use do not appear to be detectable by this method. Frontiers Media S.A. 2021-08-24 /pmc/articles/PMC8421639/ /pubmed/34504443 http://dx.doi.org/10.3389/fpsyt.2021.688384 Text en Copyright © 2021 Andersen, Gerrard, Gibbons, Beach and Philibert. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Andersen, Allan
Gerrard, Meg
Gibbons, Frederick X.
Beach, Steven R. H.
Philibert, Robert
An Examination of Risk Factors for Tobacco and Cannabis Smoke Exposure in Adolescents Using an Epigenetic Biomarker
title An Examination of Risk Factors for Tobacco and Cannabis Smoke Exposure in Adolescents Using an Epigenetic Biomarker
title_full An Examination of Risk Factors for Tobacco and Cannabis Smoke Exposure in Adolescents Using an Epigenetic Biomarker
title_fullStr An Examination of Risk Factors for Tobacco and Cannabis Smoke Exposure in Adolescents Using an Epigenetic Biomarker
title_full_unstemmed An Examination of Risk Factors for Tobacco and Cannabis Smoke Exposure in Adolescents Using an Epigenetic Biomarker
title_short An Examination of Risk Factors for Tobacco and Cannabis Smoke Exposure in Adolescents Using an Epigenetic Biomarker
title_sort examination of risk factors for tobacco and cannabis smoke exposure in adolescents using an epigenetic biomarker
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421639/
https://www.ncbi.nlm.nih.gov/pubmed/34504443
http://dx.doi.org/10.3389/fpsyt.2021.688384
work_keys_str_mv AT andersenallan anexaminationofriskfactorsfortobaccoandcannabissmokeexposureinadolescentsusinganepigeneticbiomarker
AT gerrardmeg anexaminationofriskfactorsfortobaccoandcannabissmokeexposureinadolescentsusinganepigeneticbiomarker
AT gibbonsfrederickx anexaminationofriskfactorsfortobaccoandcannabissmokeexposureinadolescentsusinganepigeneticbiomarker
AT beachstevenrh anexaminationofriskfactorsfortobaccoandcannabissmokeexposureinadolescentsusinganepigeneticbiomarker
AT philibertrobert anexaminationofriskfactorsfortobaccoandcannabissmokeexposureinadolescentsusinganepigeneticbiomarker
AT andersenallan examinationofriskfactorsfortobaccoandcannabissmokeexposureinadolescentsusinganepigeneticbiomarker
AT gerrardmeg examinationofriskfactorsfortobaccoandcannabissmokeexposureinadolescentsusinganepigeneticbiomarker
AT gibbonsfrederickx examinationofriskfactorsfortobaccoandcannabissmokeexposureinadolescentsusinganepigeneticbiomarker
AT beachstevenrh examinationofriskfactorsfortobaccoandcannabissmokeexposureinadolescentsusinganepigeneticbiomarker
AT philibertrobert examinationofriskfactorsfortobaccoandcannabissmokeexposureinadolescentsusinganepigeneticbiomarker